Literature DB >> 2557758

Human papillomaviruses and carcinomas.

D A Galloway1, J K McDougall.   

Abstract

The recognition of multiple types of human papillomaviruses has resulted in remarkable progress in the detection of persisting viral nucleic acid sequences in carcinomas. The consistent transcription in tumors of two early open reading frames, E6 and E7, with few exceptions (Lehn et al., 1985), indicates a role for the products of these genes in the induction and/or maintenance of the transformed state. A number of studies have shown that in vitro transformation can be achieved by transfection of E6/E7 DNA, and proteins encoded by these DNA sequences can be demonstrated in primary human keratinocytes immortalized by this DNA (Kaur et al., 1989). Mutagenesis experiments are needed to determine the absolute requirement for and function of these genes in transformation. A preferential association of some types with benign lesions while others may be frequently found in malignant tumors has been observed. HPV types 5 and 8 in epidermodysplasia verruciformis patients and types 16, 18, 31, 33, etc. in genital lesions are most frequently associated with progression to malignancy, whereas other types, such as HPV-6,-10, -11, and -20, are regularly identified in benign warts. Such distinctions are not absolute but provide the initial steps toward establishing a causal role for some human papillomaviruses in carcinomas. The need for well-designed epidemiological studies in concert with optimum molecular and serologic evaluations is evident (Armstrong et al., 1988). The data from human and animal studies indicate that papillomaviruses contribute significantly to the development of many, if not all, carcinomas, but we do not yet have a clear understanding of the importance of other interacting viral, chemical, or cellular factors. The application of gene cloning and non-stringent hybridization (Law et al., 1979) has provided us with an apparently ever-increasing catalog of human papillomaviruses. More effort is now required to establish their prevalence, the natural history of infection, and the mechanism of neoplastic transformation.

Entities:  

Mesh:

Year:  1989        PMID: 2557758     DOI: 10.1016/s0065-3527(08)60834-9

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  20 in total

1.  Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture.

Authors:  R A Blanton; N Perez-Reyes; D T Merrick; J K McDougall
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 2.  Cancer of the cervix: prospects for immunological control.

Authors:  D H Davies; G A McIndoe; B M Chain
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

3.  Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient.

Authors:  Shaniece Theodore; Starlette Sharp; Jianjun Zhou; Timothy Turner; Hongzhen Li; Jun Miki; Youngmi Ji; Vyomesh Patel; Clayton Yates; Johng S Rhim
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

4.  Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs.

Authors:  C Zhao; W Tan; M Sokolowski; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.

Authors:  C G Ullman; P I Haris; D A Galloway; V C Emery; S J Perkins
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

6.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Authors:  L P Chen; E K Thomas; S L Hu; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  Human papillomavirus associated with oesophageal cancer.

Authors:  T Matsha; R Erasmus; A B Kafuko; D Mugwanya; A Stepien; M I Parker
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

8.  Prevalence of genital human papillomavirus infections in patients at a sexually transmitted diseases clinic.

Authors:  Y L Chang; C Y Lin; C J Tseng; H S Cheng; H C Lin; C C Pao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

9.  Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.

Authors:  I Tarpey; S Stacey; J Hickling; H D Birley; A Renton; A McIndoe; D H Davies
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes.

Authors:  L Chen; S Ashe; M C Singhal; D A Galloway; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.